Novel therapeutic strategies for ischemic heart disease

Pharmacological Research

Volumn 89, Issue , 2014, Pages 36-45

  Perricone, Adam J ^a   Vander Heide, Richard S ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cardioprotection; Cytoskeletal signaling; Ischemia reperfusion; Ischemic preconditioning; Myocardial infarction; Reperfusion injury

Indexed keywords

ADENOSINE; ALLOPURINOL; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALDARET; CARIPORIDE; CYCLOSPORIN A; DELTA OPIATE RECEPTOR AGONIST; ENIPORIDE; VITAMIN; CARDIOTONIC AGENT;

CALCIUM CELL LEVEL; CELL DEATH; CLINICAL TRIAL (TOPIC); CORONARY ARTERY BYPASS SURGERY; DRUG EFFICACY; DRUG RESPONSE; HEART CONTRACTION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; MITOCHONDRIAL PERMEABILITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PH; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TREATMENT INDICATION; VITAMIN SUPPLEMENTATION; ANIMAL; CYTOSKELETON; DRUG EFFECTS; MYOCARDIAL ISCHEMIA; PHYSIOLOGY;

ANIMALS; CARDIOTONIC AGENTS; CYTOSKELETON; HUMANS; MYOCARDIAL ISCHEMIA; SIGNAL TRANSDUCTION;

EID: 84921524726     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2014.08.004     Document Type: Review

References (120)

1. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, and W.B. Borden Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
2. M. Heron Deaths: leading causes for 2008 Natl Vital Stat Rep 60 2012 1 94
3. F.J. Schoen, and R.N. Mitchell The heart V. Kumar, A.K. Abbas, N. Fausto, J.C. Aster, Robbins and Cotran pathologic basis of disease 2010 Saunders Philadelphia 529 587
4. P.Z. Gerczuk, and R.A. Kloner An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials J Am Coll Cardiol 59 2012 969 978
5. R.S. Vander Heide, and C. Steenbergen Cardioprotection and myocardial reperfusion: pitfalls to clinical application Circ Res 113 2013 464 477
6. V. Kumar, A.K. Abbas, N. Fausto, and J.C. Aster Cellular responses to stress and toxic insults: adaptation, injury, and death V. Kumar, A.K. Abbas, N. Fausto, J.C. Aster, Robbins and Cotran pathologic basis of disease 2010 Saunders Philadelphia 3 42
7. R.A. Gottlieb, K.O. Burleson, R.A. Kloner, B.M. Babior, and R.L. Engler Reperfusion injury induces apoptosis in rabbit cardiomyocytes J Clin Invest 94 1994 1621 1628
8. Z.Q. Zhao, D.A. Velez, N.P. Wang, K.O. Hewan-Lowe, M. Nakamura, and R.A. Guyton Progressively developed myocardial apoptotic cell death during late phase of reperfusion Apoptosis 6 2001 279 290
9. H. Fliss, and D. Gattinger Apoptosis in ischemic and reperfused rat myocardium Circ Res 79 1996 949 956
10. K. Imahashi, M.D. Schneider, C. Steenbergen, and E. Murphy Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury Circ Res 95 2004 734 741
11. S. Shimizu, Y. Eguchi, W. Kamiike, S. Waguri, Y. Uchiyama, and H. Matsuda Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions Oncogene 12 1996 2045 2050
12. R.A. Gottlieb, and R.L. Engler Apoptosis in myocardial ischemia-reperfusion Ann N Y Acad Sci 874 1999 412 426
13. A. Degterev, Z. Huang, M. Boyce, Y. Li, P. Jagtap, and N. Mizushima Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury Nat Chem Biol 1 2005 112 119
14. C.C. Smith, and D.M. Yellon Necroptosis, necrostatins and tissue injury J Cell Mol Med 15 2011 1797 1806
15. C.C. Smith, S.M. Davidson, S.Y. Lim, J.C. Simpkin, J.S. Hothersall, and D.M. Yellon Necrostatin: a potentially novel cardioprotective agent Cardiovasc Drugs Ther 21 2007 227 233
16. S. Sanada, I. Komuro, and M. Kitakaze Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures Am J Physiol Heart Circ Physiol 301 2011 H1723 H1741
17. A.T. Turer, and J.A. Hill Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy Am J Cardiol 106 2010 360 368
18. M. Chiong, Z.V. Wang, Z. Pedrozo, D.J. Cao, R. Troncoso, and M. Ibacache Cardiomyocyte death: mechanisms and translational implications Cell Death Dis 2 2011 e244
19. +exchanger in cardiac ischemia/reperfusion injury Med Sci Monit 18 2012 RA161 RA165
20. S. Orrenius, B. Zhivotovsky, and P. Nicotera Regulation of cell death: the calcium-apoptosis link Nat Rev Mol Cell Biol 4 2003 552 565
21. R.B. Jennings, H.M. Sommers, P.B. Herdson, and J.P. Kaltenbach Ischemic injury of myocardium Ann N Y Acad Sci 156 1969 61 78
22. K.A. Reimer, and R.B. Jennings The wavefront phenomenon of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow Lab Invest 40 1979 633 644
23. R.B. Jennings, H.M. Sommers, G.A. Smyth, H.A. Flack, and H. Linn Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog Arch Pathol 70 1960 68 78
24. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N Engl J Med 357 2007 1121 1135
25. I. Szabo, P. Bernardi, and M. Zoratti Modulation of the mitochondrial megachannel by divalent cations and protons J Biol Chem 267 1992 2940 2946
26. C.E. Ganote, and R.S. Vander Heide Cytoskeletal lesions in anoxic myocardial injury. A conventional and high-voltage electron-microscopic and immunofluorescence study Am J Pathol 129 1987 327 344
27. J. Inserte, V. Hernando, and D. Garcia-Dorado Contribution of calpains to myocardial ischaemia/reperfusion injury Cardiovasc Res 96 2012 23 31
28. A.P. Halestrap What is the mitochondrial permeability transition pore J Mol Cell Cardiol 46 2009 821 831
29. +and is a causative event in the death of myocytes in postischemic reperfusion of the heart J Biol Chem 276 2001 2571 2575
30. E.J. Griffiths, and A.P. Halestrap Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion Biochem J 307 Pt 1 1995 93 98
31. A.P. Halestrap, S.J. Clarke, and S.A. Javadov Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection Cardiovasc Res 61 2004 372 385
32. K. Iizuka, H. Kawaguchi, and A. Kitabatake Effects of thiol protease inhibitors on fodrin degradation during hypoxia in cultured myocytes J Mol Cell Cardiol 25 1993 1101 1109
33. X. Liu, and R.G. Schnellmann Calpain mediates progressive plasma membrane permeability and proteolysis of cytoskeleton-associated paxillin, talin, and vinculin during renal cell death J Pharmacol Exp Ther 304 2003 63 70
34. R.S. Vander Heide, and C.E. Ganote Increased myocyte fragility following anoxic injury J Mol Cell Cardiol 19 1987 1085 1103
35. C. Steenbergen, M.L. Hill, and R.B. Jennings Cytoskeletal damage during myocardial ischemia: changes in vinculin immunofluorescence staining during total in vitro ischemia in canine heart Circ Res 60 1987 478 486
36. R.S. Vander Heide, J.P. Angelo, R.A. Altschuld, and C.E. Ganote Energy dependence of contraction band formation in perfused hearts and isolated adult myocytes Am J Pathol 125 1986 55 68
37. H.M. Piper, D. Garcia-Dorado, and M. Ovize A fresh look at reperfusion injury Cardiovasc Res 38 1998 291 300
38. C.E. Ganote, and J.P. Kaltenbach Oxygen-induced enzyme release: early events and a proposed mechanism J Mol Cell Cardiol 11 1979 389 406
39. R.S. Vander Heide, and C.E. Ganote Caffeine-induced myocardial injury in calcium-free perfused rat hearts Am J Pathol 118 1985 55 65
40. 2+-free perfused rat hearts. Relationship to the calcium paradox Am J Pathol 123 1986 351 364
41. D. Garcia-Dorado, P. Theroux, J.M. Duran, J. Solares, J. Alonso, and E. Sanz Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion Circulation 85 1992 1160 1174
42. J.L. Zweier, and M.A. Talukder The role of oxidants and free radicals in reperfusion injury Cardiovasc Res 70 2006 181 190
43. D.B. Zorov, C.R. Filburn, L.O. Klotz, J.L. Zweier, and S.J. Sollott Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes J Exp Med 192 2000 1001 1014
44. S.L. Thompson-Gorman, and J.L. Zweier Evaluation of the role of xanthine oxidase in myocardial reperfusion injury J Biol Chem 265 1990 6656 6663
45. M. Crompton, S. Virji, V. Doyle, N. Johnson, and J.M. Ward The mitochondrial permeability transition pore Biochem Soc Symp 66 1999 167 179
46. R.N. Jones, K.A. Reimer, M.L. Hill, and R.B. Jennings Effect of hypothermia on changes in high-energy phosphate production and utilization in total ischemia J Mol Cell Cardiol 14 Suppl. 3 1982 123 130
47. H. Wei, W. Campbell, and R.S. Vander Heide Heat shock-induced cardioprotection activates cytoskeletal-based cell survival pathways Am J Physiol Heart Circ Physiol 291 2006 H638 H647
48. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
49. R.S. Vander Heide, L.M. Schwartz, and K.A. Reimer The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog Cardiovasc Res 28 1994 1526 1532
50. G.S. Liu, J. Thornton, D.M. Van Winkle, A.W. Stanley, R.A. Olsson, and J.M. Downey Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart Circulation 84 1991 350 356
51. Z. Bankwala, S.L. Hale, and R.A. Kloner Alpha-adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning Circulation 90 1994 1023 1028
52. J. Schultz Je, A.K. Hsu, H. Nagase, and G.J. Gross TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels Am J Physiol 274 1998 H909 H914
53. M.V. Cohen, and J.M. Downey Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease Annu Rev Med 47 1996 21 29
54. D.M. Yellon, A.M. Alkhulaifi, and W.B. Pugsley Preconditioning the human myocardium Lancet 342 1993 276 277
55. R. Bolli, Q.H. Li, X.L. Tang, Y. Guo, Y.T. Xuan, and G. Rokosh The late phase of preconditioning and its natural clinical application - gene therapy Heart Fail Rev 12 2007 189 199
56. M. Goto, Y. Liu, X.M. Yang, J.L. Ardell, M.V. Cohen, and J.M. Downey Role of bradykinin in protection of ischemic preconditioning in rabbit hearts Circ Res 77 1995 611 621
57. J.E. Schultz, A.K. Hsu, and G.J. Gross Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart Circ Res 78 1996 1100 1104
58. K. Ytrehus, Y. Liu, and J.M. Downey Preconditioning protects ischemic rabbit heart by protein kinase C activation Am J Physiol 266 1994 H1145 H1152
59. X. Yang, M.V. Cohen, and J.M. Downey Mechanism of cardioprotection by early ischemic preconditioning Cardiovasc Drugs Ther 24 2010 225 234
60. +currents by protein kinase C and adenosine, Implications for ischemic preconditioning Circ Res 78 1996 443 454
61. M. Murata, M. Akao, B. O'Rourke, and E. Marban Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca(2+) overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection Circ Res 89 2001 891 898
62. T. Matsui, L. Li, F. del Monte, Y. Fukui, T.F. Franke, and R.J. Hajjar Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro Circulation 100 1999 2373 2379
63. H. Tong, W. Chen, C. Steenbergen, and E. Murphy Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C Circ Res 87 2000 309 315
64. C.P. Baines, L. Wang, M.V. Cohen, and J.M. Downey Myocardial protection by insulin is dependent on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit heart Basic Res Cardiol 94 1999 188 198
65. H. Otani, T. Yamamura, Y. Nakao, R. Hattori, H. Kawaguchi, and M. Osako Insulin-like growth factor-I improves recovery of cardiac performance during reperfusion in isolated rat heart by a wortmannin-sensitive mechanism J Cardiovasc Pharmacol 35 2000 275 281
66. R.M. Bell, and D.M. Yellon Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS J Mol Cell Cardiol 35 2003 185 193
67. R.M. Bell, and D.M. Yellon Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway J Am Coll Cardiol 41 2003 508 515
68. D.J. Hausenloy, and D.M. Yellon New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway Cardiovasc Res 61 2004 448 460
69. D.J. Hausenloy, A. Tsang, M.M. Mocanu, and D.M. Yellon Ischemic preconditioning protects by activating prosurvival kinases at reperfusion Am J Physiol Heart Circ Physiol 288 2005 H971 H976
70. P. Ping, J. Zhang, X. Cao, R.C. Li, D. Kong, and X.L. Tang PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits Am J Physiol 276 1999 H1468 H1481
71. M. Behrends, R. Schulz, H. Post, A. Alexandrov, S. Belosjorow, and M.C. Michel Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs Am J Physiol Heart Circ Physiol 279 2000 H1111 H1119
72. M.M. Mocanu, R.M. Bell, and D.M. Yellon PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning J Mol Cell Cardiol 34 2002 661 668
73. E. Murphy, and C. Steenbergen Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury Physiol Rev 88 2008 581 609
74. M.A. Sussman, M. Volkers, K. Fischer, B. Bailey, C.T. Cottage, and S. Din Myocardial AKT: the omnipresent nexus Physiol Rev 91 2011 1023 1070
75. Y. Fujio, T. Nguyen, D. Wencker, R.N. Kitsis, and K. Walsh Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart Circulation 101 2000 660 667
76. D. Fulton, J.P. Gratton, T.J. McCabe, J. Fontana, Y. Fujio, and K. Walsh Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 1999 597 601
77. T. Miura, and M. Tanno The mPTP and its regulatory proteins: final common targets of signalling pathways for protection against necrosis Cardiovasc Res 94 2012 181 189
78. J.G. Pastorino, J.B. Hoek, and N. Shulga Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity Cancer Res 65 2005 10545 10554
79. E. Murphy, M. Kohr, J. Sun, T. Nguyen, and C. Steenbergen S-nitrosylation: a radical way to protect the heart J Mol Cell Cardiol 52 2012 568 577
80. D.L. Campbell, J.S. Stamler, and H.C. Strauss Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols J Gen Physiol 108 1996 277 293
81. J. Sun, M. Morgan, R.F. Shen, C. Steenbergen, and E. Murphy Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport Circ Res 101 2007 1155 1163
82. S.M. Nadtochiy, L.S. Burwell, and P.S. Brookes Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury J Mol Cell Cardiol 42 2007 812 825
83. T. Minamino Cardioprotection from ischemia/reperfusion injury: basic and translational research Circ J 76 2012 1074 1082
84. Z.Q. Zhao, J.S. Corvera, M.E. Halkos, F. Kerendi, N.P. Wang, and R.A. Guyton Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol 285 2003 H579 H588
85. P. Staat, G. Rioufol, C. Piot, Y. Cottin, T.T. Cung, and I. L'Huillier Postconditioning the human heart Circulation 112 2005 2143 2148
86. W.K. Laskey, S. Yoon, N. Calzada, and M.J. Ricciardi Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning Catheter Cardiovasc Interv 72 2008 212 220
87. P. Sorensson, N. Saleh, F. Bouvier, F. Bohm, M. Settergren, and K. Caidahl Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction Heart 96 2010 1710 1715
88. X. Freixa, N. Bellera, J.T. Ortiz-Perez, M. Jimenez, C. Pare, and X. Bosch Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention Eur Heart J 33 2012 103 112
89. +exchange Am J Physiol 255 1988 H608 H615
90. +exchanger are resistant to cardiac ischemia-reperfusion injury Circ Res 93 2003 776 782
91. U. Zeymer, H. Suryapranata, J.P. Monassier, G. Opolski, J. Davies, and G. Rasmanis The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction: results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial J Am Coll Cardiol 38 2001 1644 1650
92. R.M. Mentzer Jr., C. Bartels, R. Bolli, S. Boyce, G.D. Buckberg, and B. Chaitman Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study Ann Thorac Surg 85 2008 1261 1270
93. 2+exchanger confers protection against ischemia/reperfusion injury Circ Res 97 2005 916 921
94. 2+handling modulator, limits infarct size of reperfused canine heart J Pharmacol Sci 103 2007 222 233
95. F.W. Bar, D. Tzivoni, M.T. Dirksen, A. Fernandez-Ortiz, G.R. Heyndrickx, and J. Brachmann Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: the randomized multicentre CASTEMI study Eur Heart J 27 2006 2516 2523
96. G. Ambrosio, M.L. Weisfeldt, W.E. Jacobus, and J.T. Flaherty Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow Circulation 75 1987 282 291
97. W. Guan, T. Osanai, T. Kamada, H. Hanada, H. Ishizaka, and H. Onodera Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction J Cardiovasc Pharmacol 41 2003 699 705
98. Y. Ye, J. Li, and Z. Yuan Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials PLOS ONE 8 2013 e56803
99. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress Biochem J 255 1988 357 360
100. A.P. Halestrap, C.P. Connern, E.J. Griffiths, and P.M. Kerr Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury Mol Cell Biochem 174 1997 167 172
101. D.J. Hausenloy, H.L. Maddock, G.F. Baxter, and D.M. Yellon Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning Cardiovasc Res 55 2002 534 543
102. C. Piot, P. Croisille, P. Staat, H. Thibault, G. Rioufol, and N. Mewton Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 2008 473 481
103. R.B. Jennings Historical perspective on the pathology of myocardial ischemia/reperfusion injury Circ Res 113 2013 428 438
104. E.J. Griffiths, and A.P. Halestrap Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts J Mol Cell Cardiol 25 1993 1461 1469
105. X. Pan, J. Liu, T. Nguyen, C. Liu, J. Sun, and Y. Teng The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter Nat Cell Biol 15 2013 1464 1472
106. E. Basso, L. Fante, J. Fowlkes, V. Petronilli, M.A. Forte, and P. Bernardi Properties of the permeability transition pore in mitochondria devoid of cyclophilin D J Biol Chem 280 2005 18558 18561
107. B. van de Water, J.F. Nagelkerke, and J.L. Stevens Dephosphorylation of focal adhesion kinase (FAK) and loss of focal contacts precede caspase-mediated cleavage of FAK during apoptosis in renal epithelial cells J Biol Chem 274 1999 13328 13337
108. M.C. Heidkamp, A.L. Bayer, J.A. Kalina, D.M. Eble, and A.M. Samarel GFP-FRNK disrupts focal adhesions and induces anoikis in neonatal rat ventricular myocytes Circ Res 90 2002 1282 1289
109. R. Pfister, C. Acksteiner, J. Baumgarth, V. Burst, H.J. Geissler, and K.B. Margulies Loss of beta1D-integrin function in human ischemic cardiomyopathy Basic Res Cardiol 102 2007 257 264
110. J.T. Parsons Focal adhesion kinase: the first ten years J Cell Sci 116 2003 1409 1416
111. A.M. Samarel Costameres, focal adhesions, and cardiomyocyte mechanotransduction Am J Physiol Heart Circ Physiol 289 2005 H2291 H2301
112. M. Daval, T. Gurlo, S. Costes, C.J. Huang, and P.C. Butler Cyclin-dependent kinase 5 promotes pancreatic beta-cell survival via Fak-Akt signaling pathways Diabetes 60 2011 1186 1197
113. P.P. Provenzano, and P.J. Keely The role of focal adhesion kinase in tumor initiation and progression Cell Adh Migr 3 2009 347 350
114. H.R. Quinta, N.M. Galigniana, A.G. Erlejman, M. Lagadari, G. Piwien-Pilipuk, and M.D. Galigniana Management of cytoskeleton architecture by molecular chaperones and immunophilins Cell Signal 23 2011 1907 1920
115. J. Huot, H. Lambert, J.N. Lavoie, A. Guimond, F. Houle, and J. Landry Characterization of 45-kDa/54-kDa HSP27 kinase, a stress-sensitive kinase which may activate the phosphorylation-dependent protective function of mammalian 27-kDa heat-shock protein HSP27 Eur J Biochem 227 1995 416 427
116. H. Wei, and R.S. Vander Heide Heat stress activates AKT via focal adhesion kinase-mediated pathway in neonatal rat ventricular myocytes Am J Physiol Heart Circ Physiol 295 2008 H561 H568
117. H. Wei, and R.S. Vander Heide Ischemic preconditioning and heat shock activate Akt via a focal adhesion kinase-mediated pathway in Langendorff-perfused adult rat hearts Am J Physiol Heart Circ Physiol 298 2010 H152 H157
118. A.J. Perricone, B.J. Bivona, F.R. Jackson, and R.S. Vander Heide Conditional knockout of myocyte focal adhesion kinase abrogates ischemic preconditioning in adult murine hearts J Am Heart Assoc 2 2013 e000457
119. X. Wang, W. Xie, Y. Zhang, P. Lin, L. Han, and P. Han Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair Circ Res 107 2010 76 83
120. C.M. Cao, Y. Zhang, N. Weisleder, C. Ferrante, X. Wang, and F. Lv MG53 constitutes a primary determinant of cardiac ischemic preconditioning Circulation 121 2010 2565 2574